SEC Form 4 · accession 0001209191-18-017613
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP, Chief Business Officer
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 1:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 5, 2018 | M | 31,025 | — | A | 31,025 | D | |
| Ordinary Shares | Mar 5, 2018 | F | 13,836 | $15.83 | D | 17,189 | D | |
| Ordinary SharesF2 | holding | — | — | — | 131,028 | I | By Robert F. Carey III Trust dated 4/24/2001 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Mar 5, 2018 | M | 31,025 | D | — | — | Ordinary Shares | 31,025 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 35,620 ordinary shares that were previously reported as directly held by the reporting person, of which 1,430 ordinary shares were acquired by the reporting person on June 1, 2017 pursuant to an employee stock purchase program. Such shares have since been transferred by the reporting person to his living trust.
- F3On March 5, 2014, the reporting person was granted 124,100 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.